Investor Relations quality dashboard. Data-driven analysis of disclosure practices, market perception, and governance transparency.
IR Quality Score
GRS Score
62.07/100
Governance Risk
Avg Sentiment
0.7
insufficient_data
Insider Net
balanced
$0
Disclosure Freq
3.6/yr
Announcements
IR Quality Breakdown
Rank #7 of 12 in Healthcare
Sentiment Monitor
Monthly Average (12 months)
No sentiment trend data available.
Sentiment Distribution
Recent Announcements
| Date | Title | Sentiment | Direction |
|---|---|---|---|
| 27 Nov 2025 | Green Cross Health Interim Results to 30 September 2025 | positive | maintained |
Insider Activity
Total Buys
$0
Total Sells
$0
Net Direction
balanced
Monthly Insider Trades (12 months)
Recent Trades
| Director | Type | Shares | Value | Date |
|---|---|---|---|---|
| Rachael Newfield | Vesting | 114,094 | $0 | 29 May 2025 |
Earnings & Disclosure
Announcement Frequency
2025
12
ann.
2024
10
ann.
2023
21
ann.
Sector Peer Comparison
| Ticker | Company | IR Quality | GRS | Market Cap |
|---|---|---|---|---|
| RAD | Radius Residential Care Limited | 67 | 68 | $110.5M |
| PEB | Pacific Edge Limited | 63 | 73 | $209.6M |
| AFT | AFT Pharmaceuticals Limited | 48 | 77 | $367.0M |
| RUA | Rua Bioscience Limited | 39 | 76 | $10.8M |
| BAI | Being AI | 32 | 52 | $5.3M |
| SUM | Summerset Group Holdings Limited | 46 | 61 | $2.9B |
| RYM | Ryman Healthcare Limited | 49 | 68 | $2.9B |
| EBO | EBOS Group Limited | 65 | 66 | $5.8B |
| OCA | Oceania Healthcare Limited | 64 | 80 | $619.2M |
| PHL | Promisia Healthcare Limited | 54 | 73 | $24.8M |
| FPH | Fisher & Paykel Healthcare Corporation Limited | 62 | 81 | $22.2B |
Data sourced from NZX announcements, annual reports, and NZXplorer analytics. Last generated: 10 Mar 2026.
View full company profileData sourced from publicly available records. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.